What is it about?

Selective estrogen receptor modulators (SERMs), which release nitric oxide (•NO), improve desired antitumor effects and minimize unwanted side effects on the vascular system. The use of these bifunctional drugs (NO-SERMs) promises a possible improvement of the therapeutic index in breast cancer treatment.

Featured Image

Read the Original

This page is a summary of: Nitric Oxide-Releasing Selective Estrogen Receptor Modulators: A Bifunctional Approach to Improve the Therapeutic Index, Journal of Medicinal Chemistry, May 2019, American Chemical Society (ACS),
DOI: 10.1021/acs.jmedchem.9b00171.
You can read the full text:

Read

Contributors

The following have contributed to this page